Theralink Technologies, Inc.
THER
$0.0001
$0.000.00%
OTC PK
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 51.72% | -41.25% | 23.26% | 770.77% | -30.00% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 51.72% | -41.25% | 23.26% | 770.77% | -30.00% |
| Cost of Revenue | 101.65% | -38.79% | -46.81% | -45.45% | -46.68% |
| Gross Profit | -113.28% | -42.49% | 287.50% | 480.05% | 1,928.57% |
| SG&A Expenses | -40.30% | -67.39% | 28.76% | 49.99% | 87.40% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -38.01% | -67.02% | 22.40% | 46.60% | 80.09% |
| Operating Income | 39.94% | 68.10% | -22.29% | -37.56% | -86.38% |
| Income Before Tax | 47.75% | 225.12% | 363.34% | -366.58% | -2,310.65% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 47.75% | 225.12% | 363.34% | -366.58% | -2,310.65% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 47.75% | 225.12% | 363.34% | -366.58% | -2,310.65% |
| EBIT | 39.94% | 68.10% | -22.29% | -37.56% | -86.38% |
| EBITDA | 40.57% | 68.60% | -22.82% | -38.30% | -89.23% |
| EPS Basic | 47.46% | 233.33% | 333.33% | -366.67% | -1,866.67% |
| Normalized Basic EPS | 38.71% | 225.00% | 350.00% | -350.00% | -1,450.00% |
| EPS Diluted | 47.46% | 233.33% | 66.67% | -366.67% | -1,866.67% |
| Normalized Diluted EPS | 38.71% | 225.00% | 150.00% | -350.00% | -1,450.00% |
| Average Basic Shares Outstanding | 0.00% | -2.80% | 1.47% | 9.92% | 10.73% |
| Average Diluted Shares Outstanding | 0.00% | -2.80% | 248.83% | 9.92% | 10.73% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |